文献速递冠心病

RNF213变异与血管痉挛性心绞痛及致死性心肌梗死风险

RNF213 Variants, Vasospastic Angina, and Risk of Fatal Myocardial Infarction.
PubMed 文献 · JAMA Cardiol · 2024-01-01

IMPORTANCE: Vasospastic angina (VSA) is vasospasm of the coronary artery and is particularly prevalent in East Asian populations. However, the specific genetic architecture for VSA at genome-wide levels is not fully understood.…

要点

  • RNF213 rs112735431是东亚人群VSA的强效风险变异,纯合携带者效应量更大。
  • 该变异在男性和年轻人群中关联更强,符合VSA流行病学特征。
  • 无冠心病但携带风险等位基因者随访期急性心肌梗死死亡率显著增高。

核心结论

  • RNF213位点变异介导的血管细胞功能障碍可能促进冠状动脉痉挛,风险等位基因可作为预后预测因子。

主要发现

  • RNF213位点变异与VSA的关联最强(OR 2.34,95%CI 1.99-2.74,P=4.4×10^-25)。
  • 无冠心病的风险等位基因携带者随访期急性心肌梗死死亡率显著升高(HR 2.71,95%CI 1.57-4.65,P=3.3×10^-4)。

临床怎么用

  • 对东亚人群VSA患者可考虑检测RNF213 rs112735431,以识别心肌梗死高风险个体。

局限性

  • 研究基于日本人群,结果外推至其他种族需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Vasospastic angina (VSA) is vasospasm of the coronary artery and is particularly prevalent in East Asian populations. However, the specific genetic architecture for VSA at genome-wide levels is not fully understood. OBJECTIVE: To identify genetic factors associated with VSA. DESIGN, SETTING, AND PARTICIPANTS: This was a case-control genome-wide association study of VSA. Data from Biobank Japan (BBJ; enrolled patients from 2002-2008 and 2013-2018) were used, and controls without coronary artery disease (CAD) were enrolled. Patients from the BBJ were genotyped using arrays or a set of arrays. Patients recruited between 2002 and 2005 were classified within the first dataset, and those recruited between 2006 and 2008 were classified within the second dataset. To replicate the genome-wide association study in the first and second datasets, VSA cases and control samples from the latest patients in the BBJ recruited between 2013 and 2018 were analyzed in a third dataset. EXPOSURES: Single-nucleotide variants associated with VSA. MAIN OUTCOMES AND MEASURES: Cases with VSA and controls without CAD. RESULTS: A total of 5720 cases (mean [SD] age, 67 [10] years; 3672 male [64.2%]) and 153 864 controls (mean [SD] age, 62 [15] years; 77 362 male [50.3%]) in 3 datasets were included in this study. The variants at the RNF213 locus showed the strongest association with VSA across the 3 datasets (odds ratio [OR], 2.34; 95% CI, 1.99-2.74; P = 4.4 × 10-25). Additionally, rs112735431, an Asian-specific rare deleterious variant (p.Arg4810Lys) experimentally shown to be associated with reduced angiogenesis and a well-known causal risk for Moyamoya disease was the most promising candidate for a causal variant explaining the association. The effect size of rs112735431 on VSA was distinct from that of other CADs. Furthermore, homozygous carriers of rs112735431 showed an association with VSA characterized by a large effect estimate (OR, 18.34; 95% CI, 5.15-65.22; P = 7.0 × 10-6), deviating from the additive model (OR, 4.35; 95% CI, 1.18-16.05; P = .03). Stratified analyses revealed that rs112735431 exhibited a stronger association in males (χ21 = 7.24; P = .007) and a younger age group (OR, 3.06; 95% CI, 2.24-4.19), corresponding to the epidemiologic features of VSA. In the registry, carriers without CAD of the risk allele rs112735431 had a strikingly high mortality rate due to acute myocardial infarction during the follow-up period (hazard ratio, 2.71; 95% CI, 1.57-4.65; P = 3.3 × 10-4). As previously reported, a possible overlap between VSA and Moyamoya disease was not found. CONCLUSIONS AND RELEVANCE: Results of this study suggest that vascular cell dysfunction mediated by variants in the RNF213 locus may promote coronary vasospasm, and the presence of the risk allele could serve as a predictive factor for the prognosis.

来源:JAMA Cardiol,查看原文。版权归原作者所有。

引用

  1. Hikino, Koyama, Ito, et al. RNF213 Variants, Vasospastic Angina, and Risk of Fatal Myocardial Infarction. JAMA Cardiol. 2024. PMID: 38888930. doi:10.1001/jamacardio.2024.1483

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。